Canada markets open in 3 hours 16 minutes

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
33.13-3.18 (-8.76%)
At close: 04:00PM EDT
33.00 -0.13 (-0.39%)
After hours: 06:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 890.89M
Enterprise Value 629.11M
Trailing P/E N/A
Forward P/E 2.48
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.59
Price/Book (mrq)3.20
Enterprise Value/Revenue 3.99
Enterprise Value/EBITDA -26.03

Trading Information

Stock Price History

Beta (5Y Monthly) 2.64
52-Week Change 3115.13%
S&P500 52-Week Change 328.64%
52 Week High 343.81
52 Week Low 314.62
50-Day Moving Average 335.96
200-Day Moving Average 329.46

Share Statistics

Avg Vol (3 month) 3413.39k
Avg Vol (10 day) 3579k
Shares Outstanding 526.92M
Implied Shares Outstanding 626.92M
Float 824.52M
% Held by Insiders 18.84%
% Held by Institutions 191.97%
Shares Short (Feb 29, 2024) 44.22M
Short Ratio (Feb 29, 2024) 410.21
Short % of Float (Feb 29, 2024) 420.97%
Short % of Shares Outstanding (Feb 29, 2024) 415.73%
Shares Short (prior month Jan 31, 2024) 44.37M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 16, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Nov 16, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -17.82%
Operating Margin (ttm)-59.22%

Management Effectiveness

Return on Assets (ttm)-11.11%
Return on Equity (ttm)-10.83%

Income Statement

Revenue (ttm)166.8M
Revenue Per Share (ttm)6.26
Quarterly Revenue Growth (yoy)-80.80%
Gross Profit (ttm)N/A
EBITDA -75.25M
Net Income Avi to Common (ttm)-29.73M
Diluted EPS (ttm)-1.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)292M
Total Cash Per Share (mrq)10.85
Total Debt (mrq)30.22M
Total Debt/Equity (mrq)10.85%
Current Ratio (mrq)4.72
Book Value Per Share (mrq)10.38

Cash Flow Statement

Operating Cash Flow (ttm)-18.1M
Levered Free Cash Flow (ttm)-82.55M